The DNMT3L gene helps other proteins place chemical tags on DNA that guide early development and the making of eggs and sperm. This gene plays an important role in setting normal gene activity before birth. If it does not work properly, these tags may be placed incorrectly, which can disrupt fertility and imprinting (when some genes are meant to work mainly from one parent’s copy) and may affect early development.
What is a gene?
Genes are stretches of DNA that carry instructions cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly guide when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence your response to food, stress, and medications. For a deeper look at this topic, visit the LearnHub.
Overview
DNMT3LGene function
What if the gene works
The DNMT3L gene helps set normal DNA methylation, a chemical tagging system that controls which genes are active. It mainly supports this process in developing egg and sperm cells and during early embryo growth.
Risk
What if the gene does not work
Changes in the DNMT3L gene can range from milder to more severe and may reduce the placement of normal chemical tags on DNA, especially in developing eggs and sperm. This can disrupt parent-specific gene marking.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided by pathogenic variants in the DNMT3L gene in clinical guidelines. The DNMT3L gene is being studied as a possible cancer biomarker and drug target, but this has not changed routine care.
Gene function
What if the gene works
Early in development, cells need clear instructions about which genes to use and which to keep quiet. A key part of what the DNMT3L gene does is support DNA methylation, a system of chemical tags on DNA. It works mainly in early development and in the cells that become eggs or sperm.
The DNMT3L gene helps partner proteins place methyl groups, small chemical tags, onto DNA. These tags help cells control which genes stay active and which are kept quieter.
DNMT3L itself does not attach the DNA tag. Instead, it helps enzymes such as DNMT3A and DNMT3B work more effectively when new methylation patterns are being set.
This gene helps cells read marks on DNA packaging proteins, called histones. That guidance helps direct DNA methylation to places where gene activity needs tighter control.
During early development, DNMT3L supports the normal setup of gene control patterns. This is part of how cells take on the right roles as tissues begin to form.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help explain normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DNMT3L gene can change the protein’s shape, stability, or ability to bind partner proteins, which may disrupt DNA methylation (chemical tags that help control gene activity). In plain terms, how DNMT3L gene variants affect function often comes down to weaker protein interactions or less effective support of these tagging patterns. Milder variants may only partly reduce this effect, while more severe variants can greatly limit protein activity or lead to little usable protein being made.
How variants are linked to conditions
Current evidence has not established a broad, confirmed link between DNMT3L gene variants and a specific inherited health condition. Research on possible DNMT3L gene variants and health conditions is still developing, so anyone with a reported DNMT3L finding should use their doctor’s or genetic counselor’s guidance to understand what it may mean.
A variant is not necessarily a diagnosis
Genetic variants are both common in the general population and a routine part of human biology. Most do not directly affect health; they simply contribute to natural differences among people. In many genes, a variant tied to a condition suggests a potential association, not a certain diagnosis, especially when several genes and environmental influences are involved. Still, in some situations, one well-established variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the DNMT3L gene. Anyone with concerns about personal or family risk can speak with a doctor or genetic counselor.
Inheritance of DNMT3L variants
There is not yet a broadly confirmed DNMT3L gene inheritance pattern tied to a specific human condition, although this may become clearer as research develops. The DNMT3L gene is located on chromosome 21, which is an autosome, so you inherit one copy from each parent. In general, that means any DNMT3L variant can be passed from either parent to a child, regardless of sex.
What does my DNMT3L result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific, well-recognized health condition for DNMT3L, although this can change as research develops. If you have a specific DNMT3L result and want to understand what it could mean for your relatives, a doctor or genetic counselor can explain it in the context of your family history and test findings.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the DNMT3L gene, genetic testing reads your DNA from a blood sample, saliva, or a cheek swab. This is how you find out about DNMT3L variants, usually through a multigene panel, exome sequencing, or whole genome sequencing interpreted by a clinical laboratory.
When should I consider getting a genetic test?
There isn't yet a broadly established DNMT3L-specific reason for genetic testing in routine care. Testing decisions are usually based on your personal health and family history and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can be informative, but what it reveals depends on both the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body works. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment may work well for one person, seem less effective for another, or cause more side effects in someone else. Small inherited differences can change how the body breaks down a drug, moves it through the body, or responds to it at its target, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. It studies the relationship between genes and drugs to help explain why treatments can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed and individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the DNMT3L gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines work, so medication side effects, treatment choices, and other health concerns are best discussed with your doctor.
History
DNMT3L entered the scientific literature in the early 2000s, during a period when researchers were sorting out the family of genes involved in DNA methylation, a chemical tagging system that helps control gene activity. Building on this early work, scientists recognized DNMT3L as unusual because it resembled DNA methyltransferase genes but did not fit the standard pattern seen in the better known family members. Soon after, studies in mice linked DNMT3L to genomic imprinting, which helped clarify how inherited parent specific marks are established in egg and sperm cells. These findings made DNMT3L an important part of epigenetics research, especially in studies of fertility and early development. Over time, descriptions became more precise as lab methods improved and the gene’s place in this regulatory network became clearer.